Skip to main content

Table 4 Plant-derived EVs in tumor

From: Emerging applications of extracellular vesicles in tumor therapy

Source

Therapeutic agent

Targeting tumors/cells

Research models

Tumor cell lines

Outcomes

References

Citrus fruit

CML

In vivo/in vitro

LAMA84

Inhibited angiogenesis and TRAIL-mediated apoptosis and showed strong inhibitory effects in CML

Raimondo et al. (2015)

Lemon

Gastric cancer

In vitro

AGS, BGC-823, and SGC-7901

Elevated levels of le GADD45a lead to tumor cell cycle S-phase arrest and apoptosis, thereby inhibiting tumor progression

Yang et al. (2020)

Apple

Colorectal adenocarcinoma

In vitro

Caco-2

Altered function of intestinal transporter proteins

Fujita et al. (2018)

HR obtained by Salvia dominica

Pancreatic Cancer and breast cancer

In vitro

MIA PaCa-2 and MCF-7

Promoted apoptosis of cancer cells

Boccia et al. (2022)

Cannabidiol

Hepatocellular carcinoma

In vitro

HepG2 and Huh-7

Induced G0/G1 phase arrest in the cell cycle of cancer cells and induced cancer cell death by activating the mitochondria-dependent apoptotic signaling pathway

Tajik et al. (2022)

Dendropanax morbifera, Pinus densiflora

Breast cancer and skin tumor

In vitro

A431, MCF7, and MDA-MB-231

Promoted cytotoxicity

Kim et al. (2020)

Tea leaves

Breast cancer

In vitro

MCF7 and 4T1

Increased ROS levels in breast cancer cell lines triggered mitochondrial damage in tumor cells and blocked the cell cycle, leading to apoptosis and thus retarding tumor growth

Chen et al. (2023)

Ginseng

Melanoma

In vivo/in vitro

B16F10

Altered TLR4 and MyD88 signaling thereby altering M2 macrophage polarization, inhibiting melanoma growth

Cao et al. (2019)

Grapefruit

BSA and HSP70

Colon cancer

In vitro

HCT116 and DLD1

Improved uptake of exogenous proteins by human cells

Garaeva et al. (2021)

Ginger

FA and surviving protein siRNAs

KB cell derived xenograft models

In vivo/in vitro

KB

Expanded the drug activity of siRNA and inhibited tumor growth

Li et al. (2018)

Ginger

FA and DOX

IBD and CAC

In vivo/in vitro

HT-29, Caco2-BBE, and colon 26 cells

Expanded the drug activity of chemotherapeutic drugs and enhanced tumor suppression

Zhang et al. (2016b)

  1. “–”: EVs used alone, not loaded with therapeutic agents